Evidera is evolving
Learn more
Evidera
  • Contact Us
  • Search
  • Who We Are
    • About Us
    • Executive Team
    • Who We Work With
    • Contact Us
  • What We Do
    • Real-World Evidence & Data Solutions
    • Non-Interventional Studies
    • Interventional Studies
    • Patient-Centered Research
    • Evidence Synthesis, Modeling & Communication
    • Strategic Development Consulting
    • Value & Access Consulting
    • Medical Writing
    • Implementation Science
  • Thought Leadership
    • Therapeutic Expertise
    • Investing in Innovation
    • Our Publication: The Evidence Forum
    • Publications
    • Resource Center
  • News & Events
    • Upcoming Conferences
    • Webinars
    • Newsroom
  • Careers

News Room

News Room
News & Events / News Room

Evidera Advances The Use Of DICE: A Health Economic Modeling Approach Designed To Meet HTA Requirements

April 6, 2016

Dr. Jaime Caro Wins ISPOR’s 2016 Marilyn Dix Smith Leadership Award

April 5, 2016

FDA Releases Draft Guidance on Use of the “E-RS: COPD” To Measure Respiratory Symptoms In Stable COPD

March 9, 2016

Evidera Congratulates the ISPOR MCDA Task Force on New Report Highlighting Growing Relevance of MCDA

February 1, 2016

Evidera Launches Its Alzheimer’s Disease ACE

September 15, 2015

Evidera Congratulates the COPD Foundation on the FDA Approval of the First COPD Biomarker

July 15, 2015

EMA Releases Draft Opinion on Two Patient-Reported Outcome (PRO) Measures for Evaluating New Treatments for COPD

May 11, 2015

Evidera Announces Release Of FDA Draft Guidance On Use Of The “EXACT” To Measure Symptoms Of COPD Exacerbations

January 14, 2014

‹ 1 2 3

©2025 Evidera, a PPD business. All Rights Reserved
  • Privacy Policy
  • Legal Notices
  • +1 301 654 9729 (US)
  • +44 (0) 208 576 5000 (EUR)
  • Site Map
  • Twitter
  • LinkedIn